Heinz Zwierzina, MD
University Hospital Innsbruck, Austria · Medical University Innsbruck
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Heinz Zwierzina, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:40 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00932724 · CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal CancerCytavis Biopharma GmbH · terminated · Metastatic Colorectal Cancer · principal investigator
- Ph2NCT00003984 · Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic SyndromeEuropean Organisation for Research and Treatment of Cancer - EORTC · withdrawn · Myelodysplastic Syndromes · study chair
- Ph2NCT00074074 · Infliximab in Treating Patients With Myelodysplastic SyndromeEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Myelodysplastic Syndromes · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.